(All fields required)
Please enter a valid email.
Please enter your name.
Prenatal treatment has many advantages over routine postnatal care as it may prevent irreversible brain or organ injury or even prevent the loss of the fetus as a result of disease progression. With a number of these conditions such as spinal bifida, congenital diaphragmatic hernia, or twin-to-twin transfusion syndrome, an anatomic problem with the potential to cause further damage may be corrected or mitigated before birth through fetal surgery. Both the Lim lab and Peiro lab study the development of these diseases and work to develop innovative fetal surgical techniques to improve their outcome. Research in this area has led to design of effective fetal operations that are frequently quite different from the standard approaches that are used after birth. Alternatively, with the diagnosis of other diseases such as sickle cell disease, thalassemia, immune deficiency or metabolic disease, the prenatal treatment may include a cellular transplant to the fetus. Because the fetal immune system is immature, prenatal transplantation to the fetus may be done without radiation or chemotherapy thereby greatly reducing the risks associated with this therapy. The Shaaban lab studies all aspects of prenatal transplantation and has a special interest in the development of the fetal immune system. Furthermore, the origin of lifelong disease may reside in the abnormal development of the placenta. With this understanding, the Habli Lab and the Jones lab are examining therapies to correct or compensate for abnormal placental development in order to improve newborn survival and have an enormous impact on development of numerous chronic diseases such as diabetes, hypertension and obesity. Lastly, the Keswani lab studies the remarkable regenerative and healing capacity of the fetus and is designing new therapies for devastating diseases that are acquired later in life. These treatments may include therapies for damaged skin, heart, lung, liver or nerve tissue to name a few. In this way, the study of fetal disease may have an impact on a wide variety of conditions that affect newborns, older children and even adults.
To learn more about the research we do in the Center for Fetal Cellular and Molecular Therapy, visit our faculty research labs.
General contact email FetalTherapy@cchmc.org
Anne RiestenbergAdministrative Supervisor Anne.Riestenberg@cchmc.org513-636-6259
Samantha WestenbergAdministrative Assistant Samantha.Westenberg@cchmc.org513-803-2219
Ashley ColemanAdministrative AssistantAshley.Coleman@cchmc.org513-636-1786
Aimen Shaaban M.D., Director of Research,Aimen.Shaaban@cchmc.org513-636-6259
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center